OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018

Aug 2, 2018

OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada

Jul 16, 2018

GeneDx Announces Completion of 100,000 Exome Sequences

Jun 12, 2018

OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity

Jun 11, 2018

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

May 18, 2018

OPKO Health Reports First Quarter 2018 Financial Results

May 8, 2018

OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018

May 2, 2018

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

May 1, 2018

OPKO Health to Remain on the Tel Aviv Stock Exchange

Apr 27, 2018

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes

Mar 23, 2018